{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:21:20Z","timestamp":1773865280599,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.gore.2023.101281","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:27:03Z","timestamp":1695731223000},"page":"101281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Primary hepatic metastatic epitheloid trophoblastic tumor of the uterus treated with multimodal therapy including pembrolizumab and thermoablation. Case report of an extremely rare disease and review of the literature"],"prefix":"10.1016","volume":"49","author":[{"given":"M.","family":"Helbig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jaschinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Seckl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Volkmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2023.101281_b0005","first-page":"262","article-title":"Survival of women with gestational trophoblastic neoplasia and liver metastases: is it improving?","volume":"57","author":"Ahamed","year":"2012","journal-title":"J. Reprod. Med"},{"key":"10.1016\/j.gore.2023.101281_b0010","doi-asserted-by":"crossref","first-page":"100819","DOI":"10.1016\/j.gore.2021.100819","article-title":"An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab","volume":"37","author":"Bell","year":"2021","journal-title":"Gynecol. Oncol. Rep"},{"key":"10.1016\/j.gore.2023.101281_b0015","doi-asserted-by":"crossref","first-page":"100994","DOI":"10.1016\/j.gore.2022.100994","article-title":"Persistent trophoblastic atypia on endocervical curettage found to be an epithelioid trophoblastic Tumor: A case report and review of the literature","volume":"41","author":"Brodsky","year":"2022","journal-title":"Gynecol. Oncol. Rep"},{"key":"10.1016\/j.gore.2023.101281_b0020","unstructured":"Bruce S, Sorosky J. Gestational Trophoblastic Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"10.1016\/j.gore.2023.101281_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/OGX.0000000000000978","article-title":"A Review of Current Management of Placental Site Trophoblastic Tumor and Epithelioid Trophoblastic Tumor","volume":"77","author":"Burkett","year":"2022","journal-title":"Obstet. Gynecol. Surv"},{"key":"10.1016\/j.gore.2023.101281_b0030","article-title":"Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: A case for immune checkpoint salvage therapy in trophoblastic tumors","volume":"34","author":"Clair","year":"2020","journal-title":"Gynecol. Oncol. Rep"},{"key":"10.1016\/j.gore.2023.101281_b0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/GCO.0000000000000674","article-title":"Treatment of gestational trophoblastic disease in the 2020s","volume":"33","author":"Clark","year":"2021","journal-title":"Curr. Opin. Obstet. Gynecol"},{"key":"10.1016\/j.gore.2023.101281_bib156","doi-asserted-by":"crossref","unstructured":"Cyriac et al. Etoposide, cisplatin\u2013etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia, International Journal of Gynecology & Obstetrics, Volume 115, Issue 1, 2011, Pages 37-39.","DOI":"10.1016\/j.ijgo.2011.04.017"},{"key":"10.1016\/j.gore.2023.101281_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.placenta.2021.02.013","article-title":"Gestational trophoblastic neoplasia: Novelties and challenges","volume":"116","author":"da Silva","year":"2021","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.gore.2023.101281_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jogc.2020.03.001","article-title":"408: Management of Gestational Trophoblastic Diseases","volume":"43","author":"Eiriksson","year":"2021","journal-title":"J. Obstet. Gynaecol. Can"},{"issue":"2","key":"10.1016\/j.gore.2023.101281_b0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2018.11.015","article-title":"Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database","volume":"152","author":"Frijstein","year":"2019","journal-title":"Gynecol. Oncol"},{"issue":"6","key":"10.1016\/j.gore.2023.101281_b0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41416-019-0402-0","article-title":"Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours","volume":"120","author":"Froeling","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.gore.2023.101281_b0060","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ygyno.2019.03.011","article-title":"Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy","volume":"153","author":"Gadducci","year":"2019","journal-title":"Gynecol. Oncol"},{"issue":"10110","key":"10.1016\/j.gore.2023.101281_b0070","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet. Lond. Engl"},{"key":"10.1016\/j.gore.2023.101281_b0075","doi-asserted-by":"crossref","first-page":"100574","DOI":"10.1016\/j.gore.2020.100574","article-title":"A case of multi-agent drug resistant choriocarcinoma treated with Pembrolizumab","volume":"32","author":"Goldfarb","year":"2020","journal-title":"Gynecol. Oncol. Rep"},{"key":"10.1016\/j.gore.2023.101281_b0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAP.0b013e3181b507c6","article-title":"The expression and diagnostic utility of p63 in the female genital tract","volume":"16","author":"Houghton","year":"2009","journal-title":"Adv. Anat. Pathol"},{"key":"10.1016\/j.gore.2023.101281_b0085","article-title":"A multicenter retrospective study of epithelioid trophoblastic tumors to identify the outcomes, prognostic factors, and therapeutic strategies","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol"},{"issue":"130","key":"10.1016\/j.gore.2023.101281_b0090","first-page":"228","article-title":"Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease","volume":"2020","author":"Lok","year":"1990","journal-title":"Eur. J. Cancer. Oxf. Engl"},{"key":"10.1016\/j.gore.2023.101281_b0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.gore.2023.101281_b0130","author":"Merck & Co"},{"issue":"S2","key":"10.1016\/j.gore.2023.101281_b0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int. J. Gynecol. Obstet"},{"issue":"S1","key":"10.1016\/j.gore.2023.101281_b0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","journal-title":"Int. J. Gynecol. Obstet"},{"issue":"5","key":"10.1016\/j.gore.2023.101281_b0110","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/jamaoncol.2021.0051","article-title":"Chronic Immune-Related Adverse Events Following Adjuvant Anti\u2013PD-1 Therapy for High-risk Resected Melanoma","volume":"7","author":"Patrinely","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.gore.2023.101281_b0115","doi-asserted-by":"crossref","first-page":"100782","DOI":"10.1016\/j.gore.2021.100782","article-title":"Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate","volume":"36","author":"Porter","year":"2021","journal-title":"Gynecol. Oncol. Rep"},{"key":"10.1016\/j.gore.2023.101281_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/862472","article-title":"Epithelioid Trophoblastic Tumor: A Case Report and Review of the Literature","volume":"2012","author":"Scott","year":"2012","journal-title":"Case. Rep. Obstet. Gynecol"},{"key":"10.1016\/j.gore.2023.101281_b0125","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00000478-199811000-00010","article-title":"Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma","volume":"22","author":"Shih","year":"1998","journal-title":"Am. J. Surg. Pathol"},{"issue":"10","key":"10.1016\/j.gore.2023.101281_b0135","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1055\/s-0035-1558054","article-title":"Gestational Trophoblastic Disorders: An Update in 2015","volume":"75","author":"Stevens","year":"2015","journal-title":"Geburtshilfe. Frauenheilkd"},{"key":"10.1016\/j.gore.2023.101281_b0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/PGP.0000000000000305","article-title":"PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases","volume":"36","author":"Veras","year":"2017","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol"},{"issue":"6","key":"10.1016\/j.gore.2023.101281_b0145","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/01.AOG.0000147670.68914.20","article-title":"Practice Bulletin No. 53\u2014Diagnosis and Treatment of Gestational Trophoblastic Disease:","volume":"104","author":"Walker","year":"2004","journal-title":"Obstetrics. &. Gynecology"},{"issue":"1","key":"10.1016\/j.gore.2023.101281_b0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7150\/jca.28134","article-title":"Epithelioid Trophoblastic Tumors: Treatments, Outcomes, and Potential Therapeutic Targets","volume":"10","author":"Yang","year":"2019","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.gore.2023.101281_b0155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.12998\/wjcc.v11.i4.938","article-title":"Epithelioid trophoblastic tumor of the lower uterine segment and cervical canal: A case report","volume":"11","author":"Yuan","year":"2023","journal-title":"World. J. Clin. Cases"},{"key":"10.1016\/j.gore.2023.101281_b0065","unstructured":"Gestational and Non-gestational Trophoblastic Disease. Guideline of DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032\/049, February 2022)."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578923002989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578923002989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:58:10Z","timestamp":1762480690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578923002989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":32,"alternative-id":["S2352578923002989"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2023.101281","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary hepatic metastatic epitheloid trophoblastic tumor of the uterus treated with multimodal therapy including pembrolizumab and thermoablation. Case report of an extremely rare disease and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2023.101281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101281"}}